Yıl: 2023 Cilt: 53 Sayı: 2 Sayfa Aralığı: 572 - 585 Metin Dili: İngilizce DOI: 10.55730/1300-0144.5618 İndeks Tarihi: 12-06-2023

Comparison of primary care prescriptions for old and very old hypertensive patients

Öz:
Background/aim: Elderly and very elderly individuals might be subject to different approaches for the treatment of hypertension. We aimed to compare drug utilization in hypertensive old patients and very old patients in primary care, along with the evaluation of potentially inappropriate drug prescribing. Materials and methods: In this cross-sectional study, we compared prescriptions of 65–79-year-old (old patient prescriptions [OPP], n = 433,988) vs. ≥80-year-old (very old patient prescriptions [VOPP], n = 134,079) with “essential hypertension” diagnosis, issued by 3:1 systematically-sampled primary care physicians (n = 1431) in İstanbul throughout 2016. Drug utilization patterns and distribution of antihypertensives based on drug class and combination status were evaluated. Frequency of potentially inappropriate drugs per Beers Criteria were identified and compared. Results: Antihypertensive monotherapy practice was less common in OPP than VOPP (43.3% vs. 45.3%; p < 0.001). In both groups, the most commonly prescribed drugs were beta-blockers for monotherapy (37.4% vs. 33.1%, p < 0.001) and thiazide diuretics for combined therapy (69.8% vs. 67.4%, p < 0.001). Metoprolol was the most commonly prescribed antihypertensive both in OPP and VOPP (15.3% vs. 14.8%). Furosemide was ranked 10th in OPP and 3rd in VOPP (2.7% vs. 5.5%). Cardiovascular system drugs were the most commonly encountered potentially inappropriate medications in both groups (263.9 vs. 283.4 per 10,000 prescriptions, p = 0.004). Regarding antihypertensive drugs, 2.2% of those in OPP and 2.4% of those in VOPP were identified as potentially inappropriate (p = 0.002). Conclusion: Prescribing preferences to old and very old patients mostly showed slight differences. Almost half of prescriptions comprising antihypertensive monotherapy might imply hesitancy to prescribe combinations. Overuse of risky drugs such as furosemide in both groups, especially in the very elderly, requires more attention.
Anahtar Kelime: Elderly family physician irrational prescribing hypertension

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Oliveros E, Patel H, Kyung S, Fugar S, Goldberg A et al. Hypertension in older adults: assessment, management, and challenges. Clinical Cardiology 2020; 43 (2): 99-107. https:// doi.org/10.1002/clc.23303
  • 2. Jaul E, Barron J. Age-related diseases and clinical and public health implications for the 85 years old and over population. Frontiers in Public Health 2017; 5: 335. https://doi.org/10.3389/ fpubh.2017.00335
  • 3. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. European Heart Journal 2018; 39 (33): 3021- 3104. https://doi.org/10.1093/eurheartj/ehy339
  • 4. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal 2013; 34 (28): 2159-2219. https://doi.org/10.1093/ eurheartj/eht151
  • 5. Yap AF, Thirumoorthy T, Kwan YH. Systematic review of the barriers affecting medication adherence in older adults. Geriatrics & Gerontology International 2016; 16 (10): 1093- 1101. https://doi.org/10.1111/ggi.12616
  • 6. Divo MJ, Martinez CH, Mannino DM. Ageing and the epidemiology of multimorbidity. European Respiratory Journal 2014; 44 (4): 1055-1068. https://doi. org/10.1183/09031936.00059814
  • 7. American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 Updated Beers Criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society 2015; 63 (11): 2227-2246. https://doi.org/10.1111/jgs.13702
  • 8. McCormack T, Krause T, O’Flynn N. Management of hypertension in adults in primary care: NICE guideline. British Journal of General Practice 2012; 62 (596): 163-164. https://doi. org/10.3399/bjgp12X630232
  • 9. Aksoy M, Isli F, Kadi E, Varimli D, Gursoz H et al. Evaluation of more than one billion outpatient prescriptions and eight year trend showing a remarkable reduction in antibiotic prescription in Turkey: a success model of governmental interventions at national level. Pharmacoepidemiology and Drug Safety 2021; 30 (9): 1242-1249. https://doi.org/10.1002/pds.5311
  • 10. Turkish Public Health Institution. Chronic Diseases and Risk Factors Survey in Turkey. Ankara, Turkey: Ministry of Health; 2013.
  • 11. Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ. Combination therapy versus monotherapy in reducing blood pressure: meta- analysis on 11,000 participants from 42 trials. The American Journal of Medicine 2009; 122 (3): 290-300. https://doi. org/10.1016/j.amjmed.2008.09.038
  • 12. Wang X, Chen H, Essien EJ, Wu J, Serna O et al. Risk of cardiovascular outcomes and antihypertensive triple combination therapy among elderly patients with hypertension enrolled in a Medicare Advantage Plan (MAP). American Journal of Cardiovascular Drugs 2020; 20 (6): 591-602. https:// doi.org/10.1007/s40256-020-00395-0
  • 13. Al Khaja KAJ, James H, Veeramuthu S, Tayem YI, Sridharan K et al. Antihypertensive prescribing pattern in older adults: implications of age and the use of dual single-pill combinations. High Blood Pressure & Cardiovascular Prevention 2019; 26 (6): 535-544. https://doi.org/10.1007/s40292-019-00353-1
  • 14. Burnier M, Bakris G, Williams B. Redefining diuretics use in hypertension: why select a thiazide-like diuretic? Journal of Hypertension 2019; 37 (8): 1574-1586. https://doi.org/10.1097/ HJH.0000000000002088
  • 15. Ekundayo OJ, Markland A, Lefante C, Sui X, Goode PS et al. Association of diuretic use and overactive bladder syndrome in older adults: a propensity score analysis. Archives of Gerontology and Geriatrics 2009; 49 (1): 64-68. https://doi. org/10.1016/j.archger.2008.05.002
  • 16. de Vries M, Seppala LJ, Daams JG, van de Glind EMM, Masud T et al. Fall-risk-increasing drugs: a systematic review and meta- analysis: I. cardiovascular drugs. The Journal of Post-Acute and Long-Term Care Medicine 2018; 19 (4): 371.e1-371.e9. https:// doi.org/10.1016/j.jamda.2017.12.013
  • 17. Carone L, Oxberry SG, Twycross R, Charlesworth S, Mihalyo M et al. Furosemide. Journal of Pain and Symptom Management 2016; 52 (1): 144-150. https://doi.org/10.1016/j. jpainsymman.2016.05.004
  • 18. Besharat S, Grol-Prokopczyk H, Gao S, Feng C, Akwaa F et al. Peripheral edema: a common and persistent health problem for older Americans. PLoS One 2021; 16 (12): e0260742. https:// doi.org/10.1371/journal.pone.0260742
  • 19. Rodriguez-Cillero C, Menu D, d’Athis P, Perrin S, Dipanda M et al. Potentially inappropriate use of furosemide in a very elderly population: an observational study. International Journal of Clinical Practice 2017; 71 (8): e12975. https://doi.org/10.1111/ ijcp.12975
  • 20. McMurray JJV. ACE inhibitors in cardiovascular disease — unbeatable? The New England Journal of Medicine 2008; 358 (15): 1615-1616. https://doi.org/10.1056/NEJMe0801925
  • 21. Chen R, Suchard MA, Krumholz HM, Schuemie MJ, Shea S et al. Comparative first-line effectiveness and safety of ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers: a multinational cohort study. Hypertension 2021; 78 (3): 591-603. https://doi.org/10.1161/ HYPERTENSIONAHA.120.16667
  • 22. Turgut F, Balogun RA, Abdel-Rahman EM. Renin-angiotensin- aldosterone system blockade effects on the kidney in the elderly: benefits and limitations. Clinical Journal of the American Society of Nephrology 2010; 5 (7): 1330-1339. https://doi. org/10.2215/CJN.08611209
  • 23. Glassock RJ, Winearls C. Ageing and the glomerular filtration rate: truths and consequences. Transactions of the American Clinical and Climatological Association 2009; 120: 419-428.
  • 24. ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, Dyal L et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. The New England Journal of Medicine 2008; 358 (15): 1547-1559. https://doi.org/10.1056/NEJMoa0801317
  • 25. Allen C, Donegan K. The impact of regulatory action on the co-prescribing of renin-angiotensin system blockers in UK primary care. Pharmacoepidemiology and Drug Safety 2017; 26 (7): 858-862. https://doi.org/10.1002/pds.4219
  • 26. Petty DR, Zermansky AG, Alldred DP. The scale of repeat prescribing--time for an update. BMC Health Services Research 2014; 14: 76. https://doi.org/10.1186/1472-6963-14-76
  • 27. Ripley TL, Saseen JJ. β-blockers: a review of their pharmacological and physiological diversity in hypertension. Annals of Pharmacotherapy 2014; 48 (6): 723-733. https://doi. org/10.1177/1060028013519591
  • 28. Poirier L, Tobe SW. Contemporary use of β-blockers: clinical relevance of subclassification. Canadian Journal of Cardiology 2014; 30 (5): S9-S15. https://doi.org/10.1016/j.cjca.2013.12.001
  • 29. Mo L, Ding D, Pu SY, Liu QH, Li H et al. Patients aged 80 years or older are encountered more potentially inappropriate medication use. Chinese Medical Journal 2016; 129 (1): 22-27. https://doi.org/10.4103/0366-6999.172558
  • 30. Slim HB, Black HR, Thompson PD. Older blood pressure medications-do they still have a place? The American Journal of Cardiology 2011; 108 (2): 308-316. https://doi.org/10.1016/j. amjcard.2011.03.041
  • 31. Mansbart F, Kienberger G, Sönnichsen A, Mann E. Efficacy and safety of adrenergic alpha-1 receptor antagonists in older adults: a systematic review and meta-analysis supporting the development of recommendations to reduce potentially inappropriate prescribing. BMC Geriatrics 2022; 22: 771. https://doi.org/10.1186/s12877-022-03415-7
  • 32. Thorpe A, Neal D. Benign prostatic hyperplasia. Lancet 2003; 361 (9366): 1359-1367. https://doi.org/10.1016/S0140- 6736(03)13073-5
  • 33. Schilit S, Benzeroual KE. Silodosin: a selective alpha1A- adrenergic receptor antagonist for the treatment of benign prostatic hyperplasia. Clinical Therapeutics 2009; 31 (11): 2489-502. https://doi.org/10.1016/j.clinthera.2009.11.024
  • 34. Akici A, Kalaça S, Uğurlu Ü, Toklu HZ, Oktay Ş. Antihypertensive drug utilization at health centres in a district of Istanbul. Pharmacy World & Science 2007; 29 (3): 116-121. https://doi.org/10.1007/s11096-007-9103-5
  • 35. Wongrakpanich S, Wongrakpanich A, Melhado K, Rangaswami J. A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly. Aging and Disease 2018; 9 (1): 143-150. https://doi.org/10.14336/AD.2017.0306
  • 36. Aljadhey H, Tu W, Hansen RA, Blalock SJ, Brater DC et al. Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension. BMC Cardiovascular Disorders 2012; 12: 93. https://doi. org/10.1186/1471-2261-12-93
  • 37. Baker M, Perazella MA. NSAIDs in CKD: are they safe? American Journal of Kidney Diseases 2020; 76 (4): 546-557. https://doi.org/10.1053/j.ajkd.2020.03.023
APA tulu colak s, Vizdiklar C, Kaşkal M, Aydin V, ataç ö, Akici A (2023). Comparison of primary care prescriptions for old and very old hypertensive patients. , 572 - 585. 10.55730/1300-0144.5618
Chicago tulu colak selcan,Vizdiklar Caner,Kaşkal Mert,Aydin Volkan,ataç ömer,Akici Ahmet Comparison of primary care prescriptions for old and very old hypertensive patients. (2023): 572 - 585. 10.55730/1300-0144.5618
MLA tulu colak selcan,Vizdiklar Caner,Kaşkal Mert,Aydin Volkan,ataç ömer,Akici Ahmet Comparison of primary care prescriptions for old and very old hypertensive patients. , 2023, ss.572 - 585. 10.55730/1300-0144.5618
AMA tulu colak s,Vizdiklar C,Kaşkal M,Aydin V,ataç ö,Akici A Comparison of primary care prescriptions for old and very old hypertensive patients. . 2023; 572 - 585. 10.55730/1300-0144.5618
Vancouver tulu colak s,Vizdiklar C,Kaşkal M,Aydin V,ataç ö,Akici A Comparison of primary care prescriptions for old and very old hypertensive patients. . 2023; 572 - 585. 10.55730/1300-0144.5618
IEEE tulu colak s,Vizdiklar C,Kaşkal M,Aydin V,ataç ö,Akici A "Comparison of primary care prescriptions for old and very old hypertensive patients." , ss.572 - 585, 2023. 10.55730/1300-0144.5618
ISNAD tulu colak, selcan vd. "Comparison of primary care prescriptions for old and very old hypertensive patients". (2023), 572-585. https://doi.org/10.55730/1300-0144.5618
APA tulu colak s, Vizdiklar C, Kaşkal M, Aydin V, ataç ö, Akici A (2023). Comparison of primary care prescriptions for old and very old hypertensive patients. Turkish Journal of Medical Sciences, 53(2), 572 - 585. 10.55730/1300-0144.5618
Chicago tulu colak selcan,Vizdiklar Caner,Kaşkal Mert,Aydin Volkan,ataç ömer,Akici Ahmet Comparison of primary care prescriptions for old and very old hypertensive patients. Turkish Journal of Medical Sciences 53, no.2 (2023): 572 - 585. 10.55730/1300-0144.5618
MLA tulu colak selcan,Vizdiklar Caner,Kaşkal Mert,Aydin Volkan,ataç ömer,Akici Ahmet Comparison of primary care prescriptions for old and very old hypertensive patients. Turkish Journal of Medical Sciences, vol.53, no.2, 2023, ss.572 - 585. 10.55730/1300-0144.5618
AMA tulu colak s,Vizdiklar C,Kaşkal M,Aydin V,ataç ö,Akici A Comparison of primary care prescriptions for old and very old hypertensive patients. Turkish Journal of Medical Sciences. 2023; 53(2): 572 - 585. 10.55730/1300-0144.5618
Vancouver tulu colak s,Vizdiklar C,Kaşkal M,Aydin V,ataç ö,Akici A Comparison of primary care prescriptions for old and very old hypertensive patients. Turkish Journal of Medical Sciences. 2023; 53(2): 572 - 585. 10.55730/1300-0144.5618
IEEE tulu colak s,Vizdiklar C,Kaşkal M,Aydin V,ataç ö,Akici A "Comparison of primary care prescriptions for old and very old hypertensive patients." Turkish Journal of Medical Sciences, 53, ss.572 - 585, 2023. 10.55730/1300-0144.5618
ISNAD tulu colak, selcan vd. "Comparison of primary care prescriptions for old and very old hypertensive patients". Turkish Journal of Medical Sciences 53/2 (2023), 572-585. https://doi.org/10.55730/1300-0144.5618